Product name:Abiraterone
CAS:154229-19-3
Molecular formula:C24H31NO
Molecular weight:349.509
Product description:Abiraterone is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) -- i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is formulated as the prodrugabiraterone acetate and marketed under the trade name Zytiga.